IHS Chemical Week

Regions :: Western Europe :: Germany

Report: Evonik among bidders for transdermal therapeutic system firm

1:10 PM MDT | August 1, 2013 | Francinia Protti-Alvarez

Evonik Industries is among the companies interested in bidding to acquire Lohmann Therapie-Systeme (LTS; Andernach, Germany), valued at an estimated €1 billion ($1.3 billion), according to a report from Bloomberg. Other potentially interested bidders include private equity firms EQT Partners (Stockholm), Nordic Capital (Stockholm), and BC Partners (London), the report adds. The private sale process for LTS is still in its early stages, the report says. The company is coowned by Novartis, SAP, cofounder Dietmar Hopp, and private equity firm BWK...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa